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Abstract
Background: Neurokine signaling via the release of neurally active cytokines arises from glial reactivity and is
mechanistically implicated in central nervous system (CNS) pathologies such as chronic pain, trauma,
neurodegenerative diseases, and complex psychiatric illnesses. Despite significant advancements in the
methodologies used to conjugate, incorporate, and visualize fluorescent molecules, imaging of rare yet high
potency events within the CNS is restricted by the low signal to noise ratio experienced within the CNS. The brain
and spinal cord have high cellular autofluorescence, making the imaging of critical neurokine signaling and
permissive transcriptional cellular events unreliable and difficult in many cases.
Methods: In this manuscript, we developed a method for background-free imaging of the transcriptional events
that precede neurokine signaling using targeted mRNA transcripts labeled with luminescent lanthanide chelates
and imaged via time-gated microscopy. To provide examples of the usefulness this method can offer to the field,
the mRNA expression of toll-like receptor 4 (TLR4) was visualized with traditional fluorescent in situ hybridization
(FISH) or luminescent lanthanide chelate-based in situ hybridization (LISH) in mouse BV2 microglia or J774
macrophage phenotype cells following lipopolysaccharide stimulation. TLR4 mRNA staining using LISH- and FISH-
based methods was also visualized in fixed spinal cord tissues from BALB/c mice with a chronic constriction model
of neuropathic pain or a surgical sham model in order to demonstrate the application of this new methodology in
CNS tissue samples.
Results: Significant increases in TLR4 mRNA expression and autofluorescence were visualized over time in mouse
BV2 microglia or mouse J774 macrophage phenotype cells following lipopolysaccharide (LPS) stimulation. When
imaged in a background-free environment with LISH-based detection and time-gated microscopy, increased TLR4
mRNA was observed in BV2 microglia cells 4 h following LPS stimulation, which returned to near baseline levels by
24 h. Background-free imaging of mouse spinal cord tissues with LISH-based detection and time-gated microscopy
demonstrated a high degree of regional TLR4 mRNA expression in BALB/c mice with a chronic constriction model
of neuropathic pain compared to the surgical sham model.
Conclusions: Advantages offered by adopting this novel methodology for visualizing neurokine signaling with
time-gated microscopy compared to traditional fluorescent microscopy are provided.
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Background
Neurokine signaling, which is measured by increases in
the release of neurally active proinflammatory cytokines/
chemokines and is indicated by regional low-grade glial
reactivity, is a common pathophysiology in multiple cen-
tral nervous system (CNS) disorders. Increased neuro-
kine signaling arising from microglia and astrocytes
occurs in response to injury and nociceptive events [1,
2], thus is prevalent in the establishment and mainten-
ance of chronic pain in both animal models [3] and hu-
man patients [4]. Additionally, this low-grade glial
reactivity and neurokine signaling is found in 40% or
more of patients with bipolar disorder, schizophrenia,
and obsessive-compulsive disorders [5] and is prominent
in Parkinson’s [6] and Alzheimer’s diseases [7]. The de-
velopment of new effective tools for visualizing and
quantifying neurokine signaling is thus of high priority
and interest to the neuroscience community. The detec-
tion of neurokine signaling molecules and their recep-
tors can be challenging in vivo or in vitro [8].
Biomedical imaging is limited by the properties of
established fluorescent molecules such as fluorescein, cy-
anine, and AlexaFluor dyes as they compete heavily with
CNS tissue autofluorescence, which is especially high
due to flavoprotein levels that coordinate with neuronal
excitability and metabolic activity in vivo [9, 10], as well
as reduced pyridine nucleotides (NADH, NADPH), and
common neurotransmitter precursor amino acids such
as tryptophan [11, 12]. Despite the competition with cel-
lular and tissue autofluorescence, fluorescence imaging
is the predominant method for imaging neurokine sig-
naling, wherein fluorescently conjugated target mole-
cules are detected by their absorption and emission
characteristics.
The measurement of fluorescent decay (lifetimes) has
proven that the dimension of time can also be used to
detect optical signatures for dyes, autofluorescence, and
nanoparticles [13]. Fluorescence lifetime imaging mi-
croscopy (FLIM) has been applied on light scattering
brain tissues to study the dynamics of neuronal signaling
activities with fluorophore-based fluorescence resonance
energy transfer (FRET) imaging and in the intraoperative
diagnosis of glioblastoma multiforme tumors via autoflu-
orescence detection [14]. However, these and other stud-
ies in CNS tissues detect nanosecond range lifetimes
that can have potential interference between the dyes
and CNS cellular autofluorescence as their lifetimes can
overlap.
Time-gated microscopy, whereby camera images are
acquired at pre-determined delay times relative to the
period of laser or wide-field light excitation (Fig. 1), is a
promising technique that has previously been utilized
for background-free imaging of proteins in microorgan-
isms and cells [15–17]. Unlike traditional FLIM,
time-gated microscopy better exploits the luminescence
decay properties of luminophores that have longer
Fig. 1 a Example fluorescent and luminescence lifetimes of common organic dye-derived fluorophores and autofluorescent molecules (denoted
by corresponding color boxes/peaks in a and b) in comparison to europium-derived chelates (red in a and b). b The methodology of time-gated
microscope excitation (light blue) and acquisition cycles. Colored peaks are representative of the relative short lifetimes of organic dyes and
autofluorescence to long lifetime lanthanide luminescence. Light blue boxes are illustrative of the time of light excitation (excitation time per
cycle = 100 μs), which is followed by a 10-μs period of delay before subsequent camera acquisition
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lifetimes (up to 2ms), providing contrast from autofluo-
rescence that is unachievable by traditional fluorescence
microscopy [7, 16, 18]. We have demonstrated that
time-gated imaging combined with the use of a
long-lifetime chemical probe, the recently developed
biocompatible TEGylated europium chelate BHHTEGST
(4,4′-bis-(1″,1″,1″,2″,2″,3″,3″-heptafluoro-4″,6″-hexa-
nedion-6″-yl) sulfonylamino-tetraethyleneglycol- succi-
nimidyl carbonate-o-terphenyl), can provide the
opportunity to acquire background-free images with
higher accuracy and confidence [18–21]. Unlike com-
monly used organic dyes, the luminescence lifetime of
europium chelates is much longer than that of typical
autofluorescence molecules (Fig. 1a, b), providing a
greater signal detection sensitivity and discrimination
against high levels of cellular background fluorescence
for imaging neuroinflammation when combined with
time-gating methodologies (Fig. 1b).
In order to demonstrate scenarios in which this meth-
odology could be applied to benefit neuro-imaging, in
this study, we have used cell models of immune activa-
tion and animal models of chronic pain to induce neuro-
kine signaling and associated glial reactivity. Acute pain
signals are meant to be adaptive and protective. They
are communicated by well-established nociceptive neur-
onal pathways from peripheral sensory neurons to the
dorsal horn of the spinal cord then onward to the brain
through ascending fibers of the spinothalamic tract [22].
However, peripheral nerve injury can also lead to
chronic pathological pain as continuous neurokine activ-
ity from glia and immune cells of the CNS can influence
neuronal pain circuits for months or longer following in-
jury in affected regions [23, 24]. The measurement of
neurokine signaling has been primarily focused on de-
tecting cell surface markers on activated microglia and/
or the production of cytokine molecules. Identifying the
response of other critical neurokine molecules such as
the toll-like receptor 4 (TLR4) in glia and other immune
cells that influence neuronal over-excitability helps to in-
crease our understanding of the neuroimmune interface
governing the pathophysiology of chronic pain and re-
lated diseases and disorders. The imaging of TLR4 is dif-
ficult due to the low protein expression levels of
inflammatory mediator proteins [8] and the highly glyco-
sylated surface of the TLR4 protein [25].
Biotinylated in situ hybridization (ISH) probes target-
ing mRNA coupled to streptavidin (SA)-conjugated lu-
minescent lanthanides (LISH) or fluorescent Alexafluor
dye were used in this study to characterize the presence
of TLR4 mRNA. TLR4 is directly implicated in the de-
velopment of and maintenance of chronic pain [26, 27].
It has been used as a marker of neuroinflammation fol-
lowing lipopolysaccharide (LPS) stimulation of microglia
and was linked to macrophage survival in LPS-treated
mice [28]. In order to provide examples of the usefulness
of the new methodology we are presenting in this study
in comparison to the current standard ways of visualiz-
ing mRNA transcripts, we visualized the expression of
TLR4 mRNA in microglia and macrophage cells using
the inflammatory response to LPS. We furthermore
demonstrate TLR4 mRNA expression in the
lumbar-level spinal cord using our methodology from
mice that have symptoms of chronic pain. The current
study has used luminescent europium chelate labels and
time-gated microscopy to detect the RNA transcripts as-
sociated with inflammatory events in cells and tissue
samples.
Methods
Cell culture and LPS stimulation
Mouse BV2 microglia phenotype cells and mouse J774
macrophage cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) with high glucose (4500 mg/l),
L-glutamine, sodium pyruvate, and sodium bicarbonate
(D6429 Sigma) that was supplemented with 10% fetal
bovine serum (12003C Sigma; Australian Origin), and
1% antibiotic-antimycotic (10,000 IU/ml penicillin,
10,000 μg/ml streptomycin, and 25 μg/ml of Fungizone®
Antimycotic; 15240062 Life Technologies). The murine
BV2 microglia cells were a generous gift from Prof.
Gilles Guillemin (Macquarie University, Sydney,
Australia), and J774 cells were a generous gift from
Dr. Nisha Schwarz (SAHMRI, Adelaide, Australia). Cells
were maintained in a humidified incubator with 95% air
and a 5% CO2 atmosphere at 37 °C. All cells were
sub-cultured for ISH experiments onto sterile,
RNAse-free coverslips (22 mm × 22mm) for 24–48 h in-
side six-well plates. The cells were incubated with LPS
(0.5 μg/ml; tlrl-3pelps LPS-EB Ultrapure; InvivoGen) for
the specified times under normal culture conditions.
In situ hybridization probe design and synthesis
Primers for ISH were designed for this study using Pri-
mer3 (NCBI Nucleotide), spanning exon-exon junctions
and including the protein-coding regions of the mouse
TLR4 gene. The forward primer sequence includes the
SP6 promoter sequence while the reverse primer se-
quence includes the T7 promoter sequence: TLR4 F pri-
mer with SP6 at 5′ end: 5′ATTTAGGTGACACT
ATAGAAG-TCCCTGCATAGAGGTAGTTCC 3′; R pri-
mer with T7 at 5′ end: TAATACGACTCACTATAGG
GAGA-TCCCTGAAAGGCTTGGTCTT.
BV2 microglia cells were homogenized using the Bead-
Bug Benchtop Homogenizer (Pathtech) and 0.5-mm
beadblaster tubes with zirconium beads in lysis buffer
containing 2-mercaptoethanol. Total RNA was then ex-
tracted using the PureLink® RNA Mini Kit (Life Tech-
nologies) according to the manufacturer’s instructions.
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The RNA was eluted from each column into 30 μl of
RNase-free water. RNA quality and quantity were
assessed using a Nanodrop 2000 spectrophotometer
(NanoDrop Technologies, Wilmington, DE, USA). Re-
verse transcription of each RNA sample was performed
using 1 μg of template RNA, 1 μl of 50 μM Oligo d(T)20
primer, and the Superscript IV reverse transcriptase (Life
Technologies). Superscript IV First-Strand cDNA syn-
thesis reaction: Oligo d(T)20 primer, 10 mM dNTP mix,
template RNA, and water were mixed and denatured at
65 °C for 5 min, followed by cooling for 1 min on ice. 5×
SSIV buffer, Superscript IV, 100 mM DTT, and RNAse
inhibitor (RNAse Out) were added to the cooled tem-
plate mixture and incubated at 55 °C for 10 min before
enzyme inactivation at 80 °C for 10 min to make cDNA.
Standard PCR was performed for TLR4 using mouse
BV2 cell cDNA. In each 25-μl reaction tube, there were
12.5 μl AmpliTaq Gold® 360 Master Mix (Life Technolo-
gies), 1 μl forward primer, 1 μl reverse primer, 1 μg
cDNA, and 9.5 μl RNAse/DNAse-free water. Tubes were
held at 95 °C for 10 min to activate the Taq enzyme
followed by 40 cycle repeats of 95 °C for 30 s (denature),
60 °C for 30 s (anneal), 72 °C for 60 s (extend), and a final
extension at 72 °C for 7 min. PCR products were purified
using a column extraction kit according to the manufac-
turer’s protocol (PureLink® PCR Purification Kit; Life
Technologies). PCR products were then run on a 2%
TAE gel containing SYBR Gold and photographed on a
Genesnap gel doc (Syngene) to confirm appropriate mo-
lecular weights and the absence of primer dimers. Puri-
fied PCR product was in vitro transcribed to
complimentary RNA strands using the MEGAscript® T7
Transcription Kit (AM1334; Life Technologies) accord-
ing to the manufacturer’s protocol using 200 ng of PCR
product. Biotin-UTP and biotin-CTP were incorporated
into the cRNA probe. RNA probe was purified with
LiCl2 solution, washed with EtOH, air dried, and recon-
stituted in 40 μl of RNAse/DNAse-free water. RNA
probe quality and quantity were then assessed using a
Nanodrop 2000 spectrophotometer (NanoDrop Tech-
nologies, Wilmington, DE, USA).
ISH for cellular microscopy
Cells were first washed in PBS pH 7.2 and fixed using
4% formaldehyde for 10 min and then again washed with
PBS. They were permeabilized with 70% EtOH for 30
min at 4 °C then transferred to PBT solution (PBS +
0.01% Tween-20) until use. A subset of cells from each
line (n = 6 coverslips per cell line) were pretreated before
hybridization with an endogenous biotin blocking kit
(E21390; Life Technologies). Pre-hybridization buffer
(50% formamide, 5× SSC pH 7.0, 250 μg/ml herring
sperm DNA, 5% dextran sulfate, 1× Denhardt’s solution,
0.1% Tween-20) was added to cells with 1000 ng of
cRNA probe and incubated for ~ 16 h in an incubator at
37 °C. Cells were washed 3 × 5min in 2× SSC buffer (so-
dium citrate/NaCl solution) followed by 3 × 5min
washes in PBT solution. Samples were incubated for 1 h
at room temp (~ 22 °C) with streptavidin-Alexafluor555
(SA-555) or streptavidin conjugated-BHHTEGST Euro-
pium chelate (SA-Eu). Cells were then washed 3 × 5min
in PBT solution before being mounted onto slides in
Prolong gold mounting medium containing DAPI (Mo-
lecular Probes) and photographed with wide-field mi-
croscopy (inverted Olympus IX83 or upright Olympus
BX51). The BHHTEGST SA-Eu complex was produced
as we have previously described [20], then
lanthanide-based ISH was photographed with and with-
out time-gating using a Gated Auto-synchronous Lumi-
nescence Detector (GALD) system [16, 18]. The FISH
fluorescence was quantified by determining integrated
densities, with the software ImageJ (National Institutes
of Health, Bethesda, USA) using thresholding [29]. LISH
fluorescence was measured using Zen Blue software
(Zeiss) by spline contour tool and quantified by deter-
mining mean fluorescence for each group. Prism 7
(GraphPad Software, La Jolla, USA) or Excel was used
for statistical analyses, and results were expressed as
mean ± standard error of the mean (SEM). The F test of
equality was used to test for normality of distribution in
GraphPad Prism software (version 7.04) and revealed
that there was significant variance in samples due to the
presence of high and low responding cells following LPS
treatment. Samples were therefore analyzed using the
nonparametric Mann-Whitney test that does not assume
a normal distribution, which in all cases revealed signifi-
cance between groups to be p < 0.0001.
Chronic pain “neuroinflammation” animal model
Pathogen-free adult male BALB/c mice (18–25 g, aged
8–10 weeks) were utilized for the experiments in this
study. Mice were housed under SPF conditions in
temperature (23 ± 3 °C) and light/dark cycle (12/12 h)
controlled rooms with standard rodent food and water
available ad libitum. Preceding experimentation, mice (n
= 6 sham and n = 6 injury) were habituated to the animal
holding care facility for 1 week, followed by 2 days of ex-
tensive experimenter handling and acclimatization to the
von Frey testing apparatus in order to reduce successive
handling stress. This study utilized an adapted version of
the novel graded sciatic nerve injury model of allodynia
[30], a modified CCI model based in the rat [31], where
0, 1, 2, 3, or 4 chromic gut sutures are placed around
the sciatic nerve, to develop graded behavioral allodynia
(varying degrees of allodynia) as described in detail pre-
viously [30]. To ensure the systemic chromic gut chal-
lenge was equivalent between animals [32], additional
equivalent chromic gut lengths were placed
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subcutaneously over the hip, enabling each treated ani-
mal to be exposed to a total of four equivalent chromic
gut pieces. Consequently, the injury and control treat-
ment groups in this study only included six males in
each treatment group. For this, the “injury group” re-
ceived three chromic gut sutures around the sciatic
nerve and one chromic gut suture subcutaneously,
whereas the “control group” received no sutures around
the sciatic nerve but four sutures subcutaneously. The
mice were followed to postoperative (PO) day 21 to de-
termine the extent of nerve injury.
The CCI model of sciatic nerve injury was performed at
the mid-thigh level of the left hindleg as previously de-
scribed [33]. Briefly, animals were anesthetized with iso-
fluorane (2% in oxygen). The shaved skin was cleansed with
100% ethanol, and the surgery was aseptically performed.
Zero (control group) or 3 (pain group) sterile chromic gut
sutures (cuticular 4-0 chromic gut, FS-2; Ethicon, Somer-
ville, NJ, USA) were loosely tied around the gently isolated
sciatic nerve. Once the superficial muscle overlying the
nerve was sutured, additional lengths of chromic gut were
placed subcutaneously. Animals were monitored postopera-
tively until fully ambulatory prior to the return to their
home cage and checked daily for any sign of infection. No
such cases occurred in this study. Mechanical allodynia was
assessed using the method described [30]. Briefly, mice
were subjected to 10 stimulations with 6 calibrated von
Frey filaments (0.04, 0.07, 0.16, 0.4, 0.6, and 1 g). The von
Frey filaments were applied for 1 s at 1-s intervals. Fila-
ments were not applied in ascending order of force, but ra-
ther random assignment each test session. In order to avoid
sensitization, a break of 10min was given between each set
of stimulations, with 10 stimulations per filament. This
method investigates the response frequency at each von
Frey filament, and behavioral responses were recorded as
the average number of responses out of 10 for each von
Frey stimulus. The mice were tested for mechanical allody-
nia on the following days: pre-op day 1 and post-op days 1,
5, 7, 14, and 21. Two-way ANOVA showed that at day 21
there is an overall effect of surgery and hair weight on per-
centage mean paw withdrawal. A Tukey honest significance
test was conducted with a 95% family-wise confidence level,
the groups associated with each mean in the test were
found to be normally distributed by residual, and Q-Q plots
generated with R software (version 3.5.2).
Tissue processing, ISH, and immunofluorescence
On day 21 of testing, the mice were perfused and then
incubated with 4% paraformaldehyde (PFA) for standard
fixation; n = 3 animals from each group were selected for
ISH tissue processing. To prepare coronal slices for ISH,
spinal cords were cut into 40-μm-thick free-floating sec-
tions on a cryostat. Finally, the prepared tissue slices
were stained with ISH probes using the following
protocol: tissue sections were incubated overnight in
pre-hybridization buffer (50% formamide, 5× SSC pH
7.0, 250 μg/ml herring sperm DNA, 5% dextran sulfate,
1× Denhardt’s solution, 0.1% Tween-20) with 1000 ng of
cRNA probe in an incubator at 58 °C. Sections were then
washed 2 × 30 min in 2× SSC buffer (sodium citrate/
NaCl solution with 0.1% Tween-20) followed by 2 × 30
min in 0.2× SSC buffer. Sections were washed 1 × 10
min in PBS + 0.1% Tween-20 solution (PBT). Samples
were then incubated for 1 h at room temp (~ 22 °C) with
streptavidin-Alexafluor488 (SA-488) or with streptavidin
conjugated-BHHTEGST Europium chelate (SA-BHH-
TEGST-Eu3+). Sections were then washed 3 × 5min in
PBT solution before being mounted onto slides in Pro-
long Gold Antifade Mountant (P36930, Life Technolo-
gies) and photographed with wide-field microscopy at
10x magnification (upright Olympus BX51 microscope)
with and without time-gating using a Gated
Auto-synchronous Luminescence Detector (GALD) sys-
tem [18]. SA-488 FISH was detected using 493-nm exci-
tation and 517-nm emission, and LISH was detected at
340-nm excitation and 615-nm emission. All data are
represented as mean ± SEM.
A proportion of spinal cord slices (n = 3 animals per
group, n = 3 slices per animal) underwent immunofluor-
escence (IF) for glial fibrillary active protein (GFAP) to
assess spinal cord astrocyte localization. Mouse spinal
cords (L3) were fixed with 4% PFA, paraffin embedded
and cut (5 μm) on a microtome. The tissue sections were
hydrated and then antigen retrieval was carried out
using citrate buffer (pH 6.0) for 10 min at 95 °C. Sections
were blocked for 1 h at room temp with 10% normal
donkey serum in 0.01% PBS-Triton (0.01M) before add-
ing mouse anti-GFAP conjugated to FITC (1:2000;
eBiosciences cat# 53-9892) overnight at 4 °C. Sections
were washed the next day using PBS (0.01M) 3 × 10 min
before adding DAPI nuclear stain for 5 min at room
temp before washing once more with PBS (0.01M) 3 ×
10min. Sections were cover-slipped using aqueous
mounting media (Fluoro-Gel, Proscitech, IM030) and
left to air dry. GFAP images were captured on a Leica
SP5 Scanning Confocal microscope using a 490-nm
excitation laser, and emission was detected at 525 nm
using a 20x objective. For figures, images for FISH,
LISH, and IF were adjusted equally for brightness and
contrast using Inkscape software (version 0.91, www.
inkscape.org) before arrangement into figures with
Microsoft PowerPoint software.
Lanthanide conjugation and detection
The BHHTEGST molecule contains an N-hydroxysucci-
nimide ester that enables it to be attached to streptavidin
(CN: 43-4301, Life Technologies) via the amino group of
lysine residues. For conjugation, 100 μg of streptavidin
Parker et al. Journal of Neuroinflammation           (2019) 16:65 Page 5 of 13
was exchanged into 100 mM NaHCO3 (pH 8.5) and then
mixed with a 20-fold molar excess of the BHHTEGST
ligand. After incubation for 1 h at 37 °C, the reaction
mixtures were passed through a Sephadex G-25 column
(2.0–2.5 g, 4.5-cm length, 0.9 cm ID) in 0.1× PBS (0.01%
Tween 20, CAS Number 9005-64-5, Sigma Aldrich) to
remove excess BHHTEGST. The fractions correspond-
ing to labeled conjugates were collected according to ab-
sorbance detection using an Eppendorf BioPhotometer
(280 nm and 320 nm). UV-visible absorption analysis of
BHHTEGST (NanoDrop UV spectrometer) indicated a
maximum UV absorption at 335 nm and also partial ab-
sorption at 280 nm which overlaps with that of the SA.
To evaluate the partial absorption of BHHTEGST moi-
ety in the conjugated SA, the molar extinction coeffi-
cient of the chelating tag at 335 nm and 280 nm were
separately obtained from UV-visible analysis of purified
BHHTEGST [ε335 = 3.14 × 10
4M−1 cm−1, ε280 = 1.75 ×
104M−1 cm−1]. The concentration of the BHHTEGST
was then obtained by reading the absorbance of conju-
gates at 335 nm (assuming that the extinction coefficient
of BHHTEGST does not change on the labeled anti-
body). SA concentration was obtained by subtracting the
absorbance of BHHTEGST from the absorbance of la-
beled protein at 280 nm. The number of BHHTEGST
molecules per SA then was obtained by dividing the
molar ratio of ligand to SA [20].
For the preparation of 10× fluorescence enhancing buffer
(FEB) [34], the pH of a 44ml solution of 0.1M sodium hy-
droxide solution was adjusted to 4.7 with glacial acetic acid,
then 1% by volume of Triton X-100 was added. Trioctyl-
phosphine oxide (TOPO; MW 386, 38mg) was dissolved
in ethanol (5ml) and added to the sodium acetate solution
(1.25ml). This solution was diluted to a working concentra-
tion of 1× FEB for all experiments. Coverslips with attached
cells were placed upside down on microscopy slides on 5 μl
of europium chloride [EuCl3, 20mM in 1× FEB] and 20 μl
of Prolong Gold anti-fade mounting medium with DAPI.
Spinal cord slices were mounted in PBT buffer onto glass
slides and cover slipped with 20 μl of Prolong Gold
anti-fade mounting medium with DAPI and 10 μl of euro-
pium chloride. The labeled cells and spinal cord sections
were examined using a DAPI filter on a conventional
wide-field microscope (Olympus BX51 microscope) with
and without time-gated luminescence mode using an
opto-mechanical GALD device [35].
Results
Detection of TLR4 mRNA expression and
autofluorescence in cells following LPS stimulation
Traditional fluorescent in situ hybridization (FISH) re-
vealed that baseline TLR4 mRNA expression was low in
most but not all BV2 cells (Fig. 2a). TLR4 mRNA expres-
sion in BV2 cells was significantly increased 4 h following
LPS treatment with nearly all cells being highly labeled (n
= 160 cells analyzed; Fig. 2c; p < 0.0001), and this was a
377% average increase in arbitrary fluorescence units com-
pared to the 0 h treatment group (n = 114 cells analyzed).
Cellular autofluorescence was also apparent in cells that
were exposed to LPS for the same time periods but not
exposed to any biotinylated TLR4 cRNA probe conjugated
to SA-Alexafluor555. Autofluorescence in BV2 cells was
significantly increased 4 h following LPS treatment (n = 64
cells analyzed; Fig. 2c; p < 0.0001) with an 898% average
increase in arbitrary fluorescence units compared to the 0
h treatment group (n = 139 cells analyzed). Cellular fluor-
escence was however significantly higher in TLR4
mRNA-stained BV2 cells compared to autofluorescence at
both 0 h (p < 0.0001) and 4 h (p < 0.0001).
J774 macrophage cells expressed significantly more
TLR4 mRNA on average than BV2 cells at both 0 h and 4
h time points (p < 0.0001). TLR4 mRNA expression in
J774 cells was significantly increased 4 h following LPS
treatment with a range of expression intensities (n = 90
cells analyzed; Fig. 2d; p < 0.0001), and this was a 337%
average increase in arbitrary fluorescence units compared
to the 0 h treatment group (n = 115 cells analyzed). Base-
line cellular autofluorescence was not significantly differ-
ent between BV2 cells and J774 macrophage cells at 0 h;
however, at 4 h following LPS, J774 cells had significantly
more autofluorescence than BV2 cells at the same time
point (p < 0.0001). As in BV2 microglia cells, autofluores-
cence in J774 macrophage cells was significantly increased
at 4 h following LPS treatment (n = 105 cells analyzed;
Fig. 2d; p < 0.0001) with a 13,789% average increase in ar-
bitrary fluorescence units compared to the 0 h treatment
group (n = 102 cells analyzed). However, cellular fluores-
cence of TLR4 mRNA-stained J774 cells was still signifi-
cantly higher compared to autofluorescence at both 0 h (p
< 0.0001) and 4 h (p < 0.0001).
Luminescent lanthanide chelate-based ISH (LISH) was
also used for comparison to assess TLR4 mRNA expres-
sion in BV2 cells following LPS-induced stimulation. No
background fluorescence was evident with time-gated
microscopy when samples were tested in the absence of
any probe or the absence of SA-BHHTEGST-Eu3+
(Fig. 3a). A small amount of staining was observed in
cells exposed to SA-BHHTEGST-Eu3+ at 0 h but no
RNA probe, suggesting a minimal level of endogenous
binding (Fig. 3b). Low-level expression of TLR4 mRNA
was observed at 0 h LPS stimulation (Fig. 3c–e), and
these baseline levels were significantly higher than the
RNA probe-free cells exposed to only the SA-conjugated
lanthanide chelate and europium (Fig. 3f; p < 0.001; 49%
average increase in arbitrary fluorescence units com-
pared to the SA-BHHTEGST-Eu3+ only group). In agree-
ment with our findings using FISH-based probes, TLR4
mRNA was increasingly expressed in BV2 microglia cells
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following LPS stimulation when detected by the biotinyl-
ated cRNA probe conjugated to SA-BHHTEGST-Eu3+
and time-gated microscopy; TLR4 mRNA significantly in-
creased 4 h following LPS treatment (Fig. 3f; p < 0.006;
47% average increase in arbitrary fluorescence units com-
pared to the 0 h treatment group). TLR4 mRNA levels
were then subsequently significantly decreased to near
baseline levels 24 h following LPS treatment (Fig. 3f; p <
0.005; 10% average increase in arbitrary fluorescence units
compared to the 0 h treatment group).
Measurement of the pain behavior response/glial
reactivity in mice
There was no difference in the mean percentage touch
response observed in untreated contralateral hind paw
of both sham and CCI (chronic constriction of the sci-
atic nerve) pain-induced mouse groups (Fig. 4a, b). At
day 21, the treated ipsilateral hind paw of CCI mice
showed a significantly greater mean percentage touch re-
sponse to von Frey filament (1 g), compared to
sham-operated mice (p < 0.05) (Fig. 4c, d).
TLR4 mRNA detection in mouse spinal cord tissues
Little or no staining was observed with time-gated mi-
croscopy in the presence of SA-BHHTEGST-Eu3+ che-
late alone in either surgical group (Fig. 5a, b). In the
spinal cord collected from a sham-operated surgical
mouse that did not experience mechanical allodynia
pain, TLR4 mRNA staining with biotinylated in situ
hybridization probes targeting mRNA coupled to
Fig. 2 Toll-like receptor 4 (TLR4) mRNA staining in BV2 microglia cells and J774 macrophage cells (biotinylated TLR4 cRNA probe conjugated to
streptavidin (SA)-Alexafluor555) following 0 h and 4 h of LPS stimulation (0.5 μg/ml) compared to cellular autofluorescence. a DAPI (blue) and BV2 cell
autofluorescence or TLR4 mRNA expression (orange) following LPS-induced inflammation. b DAPI (blue) and J774 cell autofluorescence or TLR4 mRNA
expression (orange) following LPS-induced inflammation. c Brightness intensities of LPS-treated BV2 cells represented in arbitrary fluorescence units. d
Brightness intensities of LPS-treated J774 cells represented in arbitrary fluorescence units. 40x magnification, scale bar = 20 μm
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Fig. 3 Luminescent lanthanide-based ISH staining in BV2 cells. a The detection of DAPI (blue; top panel) with epifluorescent microscopy and
autofluorescence (red; bottom panel) with time-gated microscopy. b The detection of DAPI (blue; top panel) with epifluorescent microscopy and
non-specific SA-Eu3+ binding (red; bottom panel) by time-gated microscopy. c–e The detection of DAPI (blue; top panel) with epifluorescent
microscopy and the detection of TLR4 mRNA (red) by luminescent lanthanide staining and time-gated microscopy at c 0 h, d 4 h, and e 24 h of
LPS-induced inflammation. f TLR4 mRNA was significantly increased from 0 to 4 h following LPS stimulation and subsequently returned to near
baseline levels of expression by 24 h. A filter with 343-nm excitation/441-nm emission was used for epifluorescent microscopy (DAPI filter); 340-
nm excitation/615-nm emission was used for SA-BHHTEGST-Eu3+ time-gated microscopy (100x magnification; scale bars = 100 μm)
Fig. 4 The mean percentage response of CCI-operated (green; n = 6) and sham-operated (orange; n = 6) mice on day 21 post-surgery (*p < 0.05)
is shown for hair weights of 1 (0.04 g), 2 (0.07 g), 3 (0.16 g), 4 (0.4 g), 5 (0.6 g), and 6 (1.0 g). Contralateral hind paw shows no difference in mean
percentage response between a CCI- and b sham-operated animals. Ipsilateral hind paw shows significant higher mean percentage response of
CCI-operated animals in hair weight 1 g (c), compared to d sham-operated (*p < 0.05). Within CCI-treated animals, the mean percentage response
was significantly higher in 0.4, 0.6, and 1 g hairs, compared to 0.04 g hair (#p < 0.05)
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streptavidin-conjugated luminescent lanthanides (LISH)
was absent using time-gated microscopy (Fig. 5c). In
contrast, LISH staining demonstrated noticeably strong
TLR4 mRNA expression in the spinal cord of a mouse
from the CCI pain group when viewed with time-gated
microscopy (Fig. 5d). A predominantly unilateral in-
crease in TLR4 mRNA was observed throughout the
spinal cord in gray matter laminae I–VII and lamina X.
Low levels of TLR4 mRNA expression on the contralat-
eral side of the spinal cord may be due to the unilateral
nature of the CCI pain induction model utilized, but this
relationship was not directly assessed in the current
study. The regions of the most intense signal were ob-
served in the pyramidal tracts, axonal trafficking areas.
TLR4 mRNA had a notably low expression throughout
the ventral horn (Fig. 5d). Each CCI group animal (n =
3) showed some TLR4 mRNA staining localized to these
regions, in two animals with high intensity, suggesting
high levels of glial reactivity were present. Two animals
from the sham-operated surgical group showed no LISH
fluorescence with wide-field microscopy or time-gated
microscopy, and one sham-operated mouse displayed a
low level of TLR4 mRNA staining on the lateral and
dorsal spinal cord edges indicating some glial reactivity
could be due to the surgical process. Although the ex-
tent of TLR4 mRNA expression observed varied between
mice from the CCI group, it was consistent within mul-
tiple L5 spinal cord slices from each animal (n = 3 slices).
Fig. 5 Fluorescence and luminescent lanthanide detection in L5 mouse spinal cords from sham-operated and CCI pain treatment mice are
shown. a, b Sham and CCI pain animal spinal cord luminescence using only SA-BHHTEGST-Eu3+ chelate staining (a; without probe) and time-
gated microscopy (b; weak area of SA-BHHTEGST-Eu3+ chelate background fluorescence indicated by arrow). c, d Sham or CCI pain animal spinal
cord luminescence using LISH-based TLR4 mRNA staining and time-gated microscopy (d; strong region of TLR4 mRNA staining indicated by
arrow). e, f Sham or CCI pain animal spinal cord luminescence using FISH (SA-Alexafluor488)-based TLR4 mRNA staining. g, h Sham or CCI pain
animal spinal cord luminescence using GFAP immunofluorescence (IF), arrows indicate regions positive for GFAP protein. Scale bars = 100 μm
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This suggests that there was a varying extent of glial re-
activity and neurokine signaling in each animal.
For determination of detection sensitivity and compe-
tition with autofluorescence in tissue slices, TLR4
mRNA was also stained using FISH (tagged with
SA-488) on additional sections from corresponding test
mice. As expected, tissue autofluorescence was present
in the mouse spinal cords in both treatment groups and
competed with FISH detection of TLR4 mRNA
(Fig. 5c—sham animal and Fig. 5d—CCI pain animal)
making an accurate observation of regional TLR4
mRNA more difficult, particularly in the gray matter. In
association with our TLR4 mRNA expression findings in
the mouse spinal cord, we also observed a variable ex-
tent of astrocyte protein expression in mice from each
group (n = 3 per group). Corresponding GFAP
protein-stained sections taken from the same animals
described above showed evidence of astrocyte-specific
protein expressed in some but not all regions where
TLR4 mRNA staining was observed (Fig. 5e—sham ani-
mal and Fig. 5f—CCI pain animal). This glial reactivity
was highest in the ventral, dorsal, and lateral white mat-
ter spinal cord regions.
Discussion
In the current study, we have highlighted two methods
for visualizing molecular events associated with neuro-
kine signaling in cells and tissue samples and have pro-
vided insight into dynamic TLR4 mRNA expression in
microglia and macrophage cultured cells as well as in
the spinal cord of an animal model of inflammation
stimulated by pain. LISH-based mRNA staining results
were comparable to using FISH for staining LPS-treated
cultured microglial and macrophage cells. More dramat-
ically, while FISH can be a valuable tool for measuring
levels of neurokine signaling, long luminescent lifetime
europium chelate conjugates visualized with time-gated
microscopy (LISH) in neuronal tissue slices helped to
abolish the competing fluorescent emission from tissue
autofluorescence and enabled vastly superior resolution.
Lumbar level spinal cord autofluorescence is so appar-
ent in rodent models of chronic pain that, in fact, auto-
fluorescent flavoprotein imaging has been described as
one direct method of visualizing regional increases in
neuronal excitability and metabolic activity in vivo [9,
10]. The excitation and emission of endogenous flavo-
proteins occurs in the spectrum overlapping the most
common commercial dyes excited by blue light (these
include FITC, Alexafluor488, and Dylight488), therefore
making nucleic acid probe and antibody targeting par-
ticularly challenging across the blue/green spectrum
[11]. Additionally, unlike astrocytes, activated microglia
and macrophages display substantial autofluorescent sig-
nals in rat brain in response to blue and green/yellow
light excitation following neuronal injury due to an ac-
cumulation of lipofuscin granules [36].
Lipofuscin-derived autofluorescence is also apparent in
activated microglia and infiltrating macrophages in the
cortex of mice 3 days post treatment with i.p. LPS (5
mg/kg) [37], which may explain the noticeable increases
in autofluorescence observed over time for the cellular
models utilized in our study following LPS stimulation.
We have presented evidence of competition with spinal
cord tissue autofluorescence during blue light excitation
when staining for TLR4 mRNA using a SA-488 tagged
FISH probe. As demonstrated here for the detection of
mRNA transcripts and previously to detect protein
staining with an antibody, the use of long fluorescence
lifetime europium chelates and time-gated microscopy
provides the means to image cells and tissue slices with
a background fluorescence-free environment. It is also
possible to utilize other luminescent lanthanides such as
terbium (Tb3+; λex = 350 nm, λem = 550 nm) as
bio-probes with long lifetimes (> 100 μs) that are com-
patible with time-gated imaging [38, 39]. In this way, fu-
ture studies could incorporate a multiplexed LISH
approach for the simultaneous detection of more than
one mRNA transcript.
RNA probes coupled to labeled molecules have con-
tributed significantly to our understanding of RNA dis-
tribution throughout the brain and spinal cord and have
identified neurochemical codes for some functional CNS
cell subpopulations [40, 41]. They offer a valuable tool
for detecting neurokine molecule expression and re-
sponses. This is particularly useful when protein identifi-
cation is difficult due to poor antibodies and low protein
copy numbers. Our findings agree with a previous report
using real-time PCR in BV2 microglia cells that TLR4
mRNA is upregulated in a time-dependent manner fol-
lowing LPS stimulation, being highly significantly
upregulated 4 h following LPS treatment [42]. In the
current study, we were able to visualize these increases
in TLR4 mRNA with fluorescent and luminescent
lanthanide-based in situ hybridization and demonstrated
that multiple cell phenotypes present in CNS tissue
cross sections are capable of expressing TLR4 in re-
sponse to inflammation. The comparability of our find-
ings with different FISH conjugation methods and their
agreement with previous other techniques quantifying
TLR4 mRNA levels, gives us confidence in our
lanthanide-based method for mRNA detection in cells,
especially in the presence of high levels of autofluores-
cence such as in the CNS.
When using cRNA probes for the detection of mRNA
in CNS tissues, it is common to use tyramide or RNAs-
cope®-based signal amplification in order to help
visualize fluorescent transcripts [43, 44]. We were able
to demonstrate using luminescent lanthanide-labeled
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probes that signal amplification is not necessary if
time-gated microscopy is used. Thus, these LISH-based
probes provide greater fluorescent background suppres-
sion for CNS molecular imaging applications. Although
the percentage increase in fluorescence detection was
not as great for LISH in comparison to FISH, this is
likely due to the drastically increased endogenous auto-
fluorescence observed in the spinal cord tissue in this
study. The autofluorescence may be associated with cel-
lular mitochondrial energy demands and/or reactive oxy-
gen species production, as has been seen in BV2 cells
following LPS treatment [45]. There was a low level of
background labeling in BV2 cells by the unconjugated
(no probe) SA-europium chelate. We initially suspected
that this labeling was due to the recognition of endogen-
ous cellular biotin by the SA-europium chelate. How-
ever, we found that pre-treatment with an endogenous
biotin blocking kit (Thermo Fisher Scientific #E21390)
did not affect our results. Even though it has been re-
ported that oligodendrocytes express higher levels of
biotin for myelin production in neuronal tissues com-
pared to other cell types, our spinal cord tissue samples
showed little or no staining with SA-europium chelate
alone. This suggests that the limited non-specific bind-
ing of SA-europium chelate is not correlated with en-
dogenous biotin, but could be due to the minor
hydrophobic/hydrophobic interaction of the europium
chelate molecule to intracellular entities. We have simi-
larly observed this low level of background labeling
using the same europium chelate for lanthanide-based
detection of DNA transcripts in Staphylococcus aureus
(unpublished work).
TLR4-driven neuroinflammation is suspected to be in-
volved in the initiation or maintenance of chronic pain
symptoms in mice. For example, intrathecal application
of LPS in mice induced increases in TLR4 mRNA levels
(determined by real-time PCR) from lumbar levels 4–6
of male mice, and a pharmacological (LPS-RS) blockade
of spinal TLR4 following spinal cord nerve injury in
male mice drastically improved behaviorally assessed
symptoms for pain [46]. Our current study provides an
insight into the regional distribution of TLR4 mRNA ex-
pression and astrocyte localization in the CCI mouse
model of chronic pain. Our findings are in agreement
with another study demonstrating similar regional GFAP
staining in the lumbar spinal cord white matter in other
models of chronic pain in mice, where the authors inter-
preted their findings as a demonstration of substantial
sustained astrogliosis [47].
As shown here, LPS stimulation resulted in increased
expression of TLR4 mRNA in both microglia and
macrophage cells. The TLR4 mRNA expression in the
spinal cord tissues could potentially be multiple cell
types within the regions. Microglia are known to express
TLR4 whereas astrocytes and oligodendrocytes normally
express little or no TLR4 mRNA [48, 49]. This suggests
some of the observed mRNA expression is likely to be
found within microglia cells in the tissue. The presence
of microglia in the spinal cord white matter could be
considered somewhat surprising, but reactive microglia
have been seen in close apposition to axons in response
to myelin reduction, which is a pathophysiology seen in
the CCI model of murine chronic pain [50]. TLR4
mRNA has been demonstrated in murine macrophage
cells from blood vessel tissues [51], and both macro-
phage and endothelial cells can bind LPS in mice follow-
ing systemic administration [52]. There is additional
evidence of macrophage cell involvement in neuroin-
flammation by their migration in response to released
cytokines and macrophage responses to injury in spinal
cord endothelial cells have also been reported [53].
Conclusions
In summary, the methods demonstrated in this study
can help neurobiologists to better visualize neurokine
signaling (or other) molecules in cells or tissue samples.
Using in situ hybridization can be a powerful tool for
visualizing localized changes in mRNA expression of
proteins that are hard to detect. We have also estab-
lished that the use of luminescent lanthanide chelates vi-
sualized by time-gated microscopy can decrease imaging
artifacts by allowing detection of the luminescent mRNA
probe in the presence of the well-described increases in
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